We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Qiagen NV | NYSE:QGEN | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.33 | -0.76% | 43.17 | 43.50 | 42.94 | 43.50 | 913,825 | 22:30:00 |
From May 2019 to May 2024
HILDEN, Germany and GERMANTOWN, Maryland, November 13, 2017 /PRNewswire/ --
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the 2,000th placement of QIAsymphony, the leading Sample to Insight workflow automation solution for molecular laboratories worldwide. The milestone means QIAGEN has already exceeded its year-end 2017 goal of exceeding 2,000 cumulative placements. The rapid dissemination of QIAsymphony systems, as well as the increasing menu and new capabilities, are fueling double-digit growth in sales of the systems' related consumables.
Click here for the full press release
https://corporate.qiagen.com/newsroom/press-releases/2017/2017-11-13-QIAsymphony?sc_lang=en
Contacts:
QIAGEN
Investor Relations
John Gilardi
+49-2103-29-11711
e-mail: ir@QIAGEN.com
Public Relations
Dr. Thomas Theuringer
+49-2103-29-11826
e-mail: pr@QIAGEN.com
SOURCE QIAGEN N.V.
Copyright 2017 PR Newswire
1 Year Qiagen NV Chart |
1 Month Qiagen NV Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
